Thrombocytopenia clinical trials at UCSF

1 research study open to eligible people

Clinical Performance Evaluation of T-TAS®01 HD Chip
open to eligible people ages 18 years and up
The study is being conducted to validate the clinical performance of the T-TAS 01 HD assay for measurement of thrombogenicity in patients with thrombocytopenia receiving a platelet transfusion.
San Francisco, California and other locations

Last updated: August 12, 2024